References
- Akhan ES (2007). The epidemiology of cervical cancer and HPV serotypes in Turkey. Ankem Dergisi, 21, 96-8.
- Altun Z, Yarkin F, Vardar MA, Uguz AH (2011). The prevalence of human papilloma virus infection among women who admitted to cukurova university faculty of medicine hospital. J Med Sci, 31, 307-14.
- Bosch FX, Manos MM, Munoz N, et al (1995). The IBSCC study group. Prevalence of human papillomavirus in cervical cancer: a worldwide experience. J Natl Cancer Inst, 87, 796-802. https://doi.org/10.1093/jnci/87.11.796
- Casalegno JS, Benchaib M, Le Bail Carval K, et al (2011). Human papillomavirus genotype distribution among French women with and without cervical abnormalities. Int J Gynaecol Obstet, 114, 116-9. https://doi.org/10.1016/j.ijgo.2011.01.030
- Chinchai T, Chansaenroj J, Junyangdikul P, et al (2011). Comparison between direct sequencing and INNO-LiPA methods for HPV detection and genotyping in Thai Women. Asian Pac J Cancer Prev, 12, 989-94.
- Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S (2003). Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer, 88, 63-73. https://doi.org/10.1038/sj.bjc.6600688
- Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S (2003). Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer, 348, 518-27.
- Clifford GM, Smith JS, Aguado T, Franceschi S (2003). Comparison of HPV type distribution in highgrade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer, 89, 101-5. https://doi.org/10.1038/sj.bjc.6601024
- Crook T, Storey A, Almond N, Osborn K, Crawford L (1988). Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells. Proc Natl Acad Sci USA, 85, 8820-4. https://doi.org/10.1073/pnas.85.23.8820
- Cuschieri KS, Cubie HA, Dunne EF, et al (2007). Prevalence of HPV infection among females in the United States. JAMA, 297, 813-9. https://doi.org/10.1001/jama.297.8.813
- Cuschieri KS, Cubie HA, Whitley MW, et al (2004). Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol, 57, 68-72. https://doi.org/10.1136/jcp.57.1.68
- Cuzick J, Szarewski A, Cubie H, et al (2003). Management of women who test is positive for high risk types of Human papillomaviruses. The Hart Study Lancet, 362, 1871-76. https://doi.org/10.1016/S0140-6736(03)14955-0
- de Sanjose S, Almirall R, Lloveras B, et al (2003). Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis, 30, 788-93. https://doi.org/10.1097/01.OLQ.0000080177.82204.E0
- de Sanjose S, Diaz M, Castellsague X, et al (2007). Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis, 7, 453-9. https://doi.org/10.1016/S1473-3099(07)70158-5
- Eroglu C, Kesli R, Eryilmaz MA, et al (2011). Serviks kanseri icin riski olan kadinlarda HPV tiplendirmesi HPV sikliginin risk faktorleri ve servikal smearla iliskisi. Nobel Med, 7, 72-7.
- GLOBOCAN (2008). The International Agency for Research on Cancer, WHO, Cancer Incidence and Mortality Worldwide in 2008 globocan.iarc.fr/.
- IARC Monographs on the Evalution of Carcinogenic Risks to Humans, Volume 90, Human Papilloma Viruses. IARC Pres. Lyon, 2007.
- International Collaboration of Epidemiological Studies of Cervical Cancer (2007). Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16573 women with cervical cancer and 35509 women without cervical cancer from 24 epidemiological studies. Lancet, 370, 1609-21. https://doi.org/10.1016/S0140-6736(07)61684-5
- Khodakarami N, Clifford GM, Yavari P, et al (2012). Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran. Int J Cancer, 131, 156-61. https://doi.org/10.1002/ijc.26488
- Munger K, Baldwin A, Edwards KM, et al (2004). Mechanisms of human papillomavirus-induced oncogenesis, J Virol, 78, 11451-60. https://doi.org/10.1128/JVI.78.21.11451-11460.2004
- Munoz N, Bosch FX, de Sanjose, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Eng J Med, 348, 518-27. https://doi.org/10.1056/NEJMoa021641
- Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
- Piana A, Sotgiu G, Castiglia P, et al (2011). Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy. BMC Public Hlth, 11, 785. https://doi.org/10.1186/1471-2458-11-785
- Pista A, de Oliveira CF, Cunha MJ, et al (2011). CLEOPATRE portugal study group. prevalence of human papillomavirus infection in women in Portugal: the CLEOPATRE Portugal study. Int J Gynecol Cancer, 21, 1150-8. https://doi.org/10.1097/IGC.0b013e31821dd3b2
- Rock CL, Michael CW, Reynolds RK, Ruffin MT (2000). Prevention of cervical cancer. Crit Rev Oncol Hematol, 33, 169-85. https://doi.org/10.1016/S1040-8428(99)00073-6
- Sauvaget C, Nene BM, Jayant K, et al (2011). Prevalence and determinants of high-risk human papillomavirus infection in middle-aged Indian women. Sex Transm Dis, 38, 902-6. https://doi.org/10.1097/OLQ.0b013e318223be5f
- Senol V, Balci E, Cetinkaya F, Elmali F (2012). Women’s knowledge and behavior on cervical cancer, in Kayseri, Turkey. J Med Sci, 32, 694-701.
- Solomon D, Davey D, Kurman R, et al (2002). The 2001 bethesda system terminology for reporting results of cervical cytology. JAMA, 16, 2114-9.
- Trottier H, Franco EL (2006). The epidemiology of genital human papillomavirus infection. Vaccine, 24, 4-15. https://doi.org/10.1016/j.vaccine.2005.09.054
- Trottier H, Mahmud S, Costa MC, et al (2006). Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev, 15, 1274-80. https://doi.org/10.1158/1055-9965.EPI-06-0129
- Vesco KK, Whitlock EP, Eder M, et al (2011). Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the U.S. preventive services task force. Ann Intern Med, 155, 698-705. https://doi.org/10.7326/0003-4819-155-10-201111150-00377
- Yuce K, Pinar A, Salman MC, et al (2012). Detection and genotyping of cervical HPV with simultaneous cervical cytology in Turkish women: a hospital-based study. Arch Gynecol Obstet, 286, 203-8. https://doi.org/10.1007/s00404-012-2280-z
Cited by
- Prevalence and Genotype Distribution of HPV among Women Attending a Cervical Cancer Screening Mobile Unit in Lampang, Thailand vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6151
- Development of In-House Multiplex Real Time PCR for Human Papillomavirus Genotyping in Iranian Women with Cervical Cancer and Cervical Intraepithelial Neoplasia vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6257
- Human Papillomavirus Genotype Distribution and E6/E7 Oncogene Expression in Turkish Women with Cervical Cytological Findings vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.3997
- Awareness and Attitude Relating to the Human Papilloma Virus and its Vaccines Among Pediatrics, Obstetrics and Gynecology Specialists in Turkey vol.15, pp.24, 2014, https://doi.org/10.7314/APJCP.2014.15.24.10723
- High grade squamous intraepithelial lesion on high-risk HPV negative patients: Why we still need the Pap test vol.46, pp.11, 2018, https://doi.org/10.1002/dc.23959